NexgenRX Inc. Cash Flow Conversion Efficiency

Latest as of September 2025: 0.106x

NexgenRX Inc. cash flow conversion efficiency. Based on the latest financial reports, NexgenRX Inc. (NXG) has a cash flow conversion efficiency ratio of 0.106x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$880.82K ≈ $637.17K USD) by net assets (CA$8.29 Million ≈ $6.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of NexgenRX Inc. (2013–2024)

Cash flow conversion efficiency of NexgenRX Inc. from 2013 to 2024. This chart illustrates how NexgenRX Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View NexgenRX Inc. stock quote for real-time trading data and today's change.

NexgenRX Inc. Cash Flow Conversion Ratio Explained

NexgenRX Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

NexgenRX Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NexgenRX Inc. ranked by their cash flow conversion efficiency. Also see NexgenRX Inc. market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Agtira AB ST:AGTIRA-B	N/A
Chonbang KO:000950	-0.001x
Cubic Digital Technology Co Ltd SHE:300344	-0.061x
Globe Industries Corp TW:1324	-0.006x
DJ Mediaprint & Logistics Limited NSE:DJML	-0.318x
AztechWB Co. Ltd KQ:032080	0.002x
LANCOR HOLDINGS LTD. NSE:LANCORHOL	0.159x
Atlantic American Corporation NASDAQ:AAME	0.061x

Annual Cash Flow Conversion Efficiency for NexgenRX Inc. (2013–2024)

The table below shows the annual cash flow conversion efficiency of NexgenRX Inc. from 2013 to 2024. Review NXG free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$7.62 Million ≈ $5.52 Million	CA$1.15 Million ≈ $832.04K	0.151x	-8.88%
2023-12-31	CA$7.71 Million ≈ $5.58 Million	CA$1.28 Million ≈ $924.01K	0.166x	+37.46%
2022-12-31	CA$8.85 Million ≈ $6.40 Million	CA$1.07 Million ≈ $771.17K	0.120x	-69.41%
2021-12-31	CA$9.71 Million ≈ $7.03 Million	CA$3.82 Million ≈ $2.77 Million	0.394x	-18.05%
2020-12-31	CA$5.52 Million ≈ $3.99 Million	CA$2.65 Million ≈ $1.92 Million	0.480x	-15.42%
2019-12-31	CA$1.84 Million ≈ $1.33 Million	CA$1.05 Million ≈ $756.44K	0.568x	+319.14%
2018-12-31	CA$1.96 Million ≈ $1.42 Million	CA$-507.38K ≈ $-367.03K	-0.259x	-97.65%
2017-12-31	CA$1.96 Million ≈ $1.42 Million	CA$-257.35K ≈ $-186.16K	-0.131x	-120.25%
2016-12-31	CA$758.06K ≈ $548.37K	CA$490.96K ≈ $355.16K	0.648x	+55.58%
2015-12-31	CA$-83.93K ≈ $-60.71K	CA$-34.94K ≈ $-25.27K	0.416x	-65.35%
2014-12-31	CA$-464.55K ≈ $-336.05K	CA$-558.18K ≈ $-403.78K	1.202x	+105.71%
2013-12-31	CA$-36.81K ≈ $-26.63K	CA$774.08K ≈ $559.95K	-21.026x	--

About NexgenRX Inc.

V:NXG Canada Health Information Services

Market Cap

$33.95 Million

CA$46.94 Million CAD

Market Cap Rank

#24435 Global

#917 in Canada

Share Price

CA$0.66

Change (1 day)

+0.00%

52-Week Range

CA$0.31 - CA$0.73

All Time High

CA$0.73